DrugPatentWatch Database Preview
Drugs in Development Information for Methoxyamine
Drug Development Status for Methoxyamine: Patents, clinical trial progress, indications
Methoxyamine is an investigational drug.
There have been 6 clinical trials for Methoxyamine.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lymphoma, and Lung Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Case Comprehensive Cancer Center, and [disabled in preview].
There are three US patents protecting this investigational drug and thirty-five international patents.
Summary for Methoxyamine
| US Patents | 3,356 |
| International Patents | 35,713 |
| US Patent Applications | 3,284 |
| WIPO Patent Applications | 2,107 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2015-12-01) |
| Vendors | 25 |
Recent Clinical Trials for Methoxyamine
| Title | Sponsor | Phase |
|---|---|---|
| Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma | National Cancer Institute (NCI) | Phase 2 |
| Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer | National Cancer Institute (NCI) | Phase 1 |
| Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Cisplatin and Pemetrexed | National Cancer Institute (NCI) | Phase 1/Phase 2 |
Clinical Trial Summary for Methoxyamine
Top disease conditions for Methoxyamine
Top clinical trial sponsors for Methoxyamine
US Patents for Methoxyamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Methoxyamine | See Pricing | 4-substituted pyrazolo[3,4-d]pyrimidine derivatives | Ortho Pharmaceutical Corporation (Raritan, NJ) | See Pricing |
| Methoxyamine | See Pricing | Macrolide compounds | American Cyanamid Company (Stamford, CT) | See Pricing |
| Methoxyamine | See Pricing | Benzo[1,8]naphthyridine derivatives, their preparation and the compositions which contain them | Laboratoire Roger Bellon (Seine, FR) | See Pricing |
| Methoxyamine | See Pricing | Inosose derivatives, production and use thereof | Takeda Chemical Industries, Ltd. (Osaka, JP) | See Pricing |
| Methoxyamine | See Pricing | 7-substituted bicyclic pyrazolidinones | Eli Lilly and Company (Indianapolis, IN) | See Pricing |
| Methoxyamine | See Pricing | Process for the preparation of substituted 3-amino-2 (benzoyl)-acrylic acid esters, and a process for the preparation of intermediates for antibacterial active compounds from these compounds | Chemie Linz Gesellschaft m.b.H. (Linz, AT) | See Pricing |
| Methoxyamine | See Pricing | Optically active hydroxybenzylamine | Sumitomo Chemical Company, Limited (Osaka, JP) | See Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Methoxyamine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Methoxyamine | Australia | 3088389 | 2008-03-03 | See Pricing |
| Methoxyamine | Australia | 612797 | 2008-03-03 | See Pricing |
| Methoxyamine | China | 1030605 | 2008-03-03 | See Pricing |
| Methoxyamine | China | 1036766 | 2008-03-03 | See Pricing |
| Methoxyamine | Denmark | 101689 | 2008-03-03 | See Pricing |
| Methoxyamine | European Patent Office | 0331510 | 2008-03-03 | See Pricing |
| Methoxyamine | Finland | 891004 | 2008-03-03 | See Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
